Literature DB >> 10530840

Prosthetic reconstruction for tumours of the distal tibia and fibula.

S H Lee1, H S Kim, Y B Park, T Y Rhie, H K Lee.   

Abstract

We have carried out prosthetic reconstruction in six patients with malignant or aggressively benign bone tumours of the distal tibia or fibula. The diagnoses were osteosarcoma in four patients, parosteal osteosarcoma in one and recurrent giant-cell tumour in one. Five tumours were in the distal tibia and one in the distal fibula. The mean duration of follow-up was 5.3 years (2.0 to 7.1). Reconstruction was achieved using custom-made, hinged prostheses which replaced the distal tibia and the ankle. The mean range of ankle movement after operation was 31 degrees and the joints were stable. The average functional score according to the system of the International Society of Limb Salvage was 24.2 and five of the patients had a good outcome. Complications occurred in two with wound infection and talar collapse. All patients were free from neoplastic disease at the latest follow-up. Prosthetic reconstruction may be used for the treatment of malignant tumours of the distal tibia and fibula in selected patients.

Entities:  

Mesh:

Year:  1999        PMID: 10530840     DOI: 10.1302/0301-620x.81b5.9588

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  23 in total

1.  Similar survival but better function for patients after limb salvage versus amputation for distal tibia osteosarcoma.

Authors:  Andreas F Mavrogenis; Caterina Novella Abati; Carlo Romagnoli; Pietro Ruggieri
Journal:  Clin Orthop Relat Res       Date:  2012-01-24       Impact factor: 4.176

Review 2.  [Total endoprosthetic replacement of femur, humerus and tibia].

Authors:  U Lenze; C Knebel; F Lenze; S Consalvo; I Lazic; S Breden; H Rechl; R von Eisenhart-Rothe
Journal:  Orthopade       Date:  2019-07       Impact factor: 1.087

3.  CORR Insights®: Is Limb Salvage With Microwave-induced Hyperthermia Better Than Amputation for Osteosarcoma of the Distal Tibia?

Authors:  Manish Agarwal
Journal:  Clin Orthop Relat Res       Date:  2017-03-06       Impact factor: 4.176

4.  Vascularized fibular medialization for reconstruction of the tibial defects following tumour excision.

Authors:  Abed El-Negery; Nabil Ahmed Elmoghazy; Mohamed Serry Abd-Ellatif; Adham Elgeidi
Journal:  Int Orthop       Date:  2017-04-19       Impact factor: 3.075

5.  Treatment of primary malignant bone tumours of the distal tibia.

Authors:  M Laitinen; J Hardes; H Ahrens; C Gebert; B Leidinger; M Langer; W Winkelmann; G Gosheger
Journal:  Int Orthop       Date:  2005-06-11       Impact factor: 3.075

Review 6.  Clinical management and surgical treatment of distal fibular tumours: a case series and review of the literature.

Authors:  Carlo Perisano; Emanuele Marzetti; Maria Silvia Spinelli; Calogero Graci; Carlo Fabbriciani; Nicola Maffulli; Giulio Maccauro
Journal:  Int Orthop       Date:  2012-04-15       Impact factor: 3.075

7.  Reconstruction of the distal tibia following resection of aggressive bone tumours using a custom-made megaprosthesis.

Authors:  P Yang; S Evans; Z Khan; A Abudu; L Jeys; R Grimer
Journal:  J Orthop       Date:  2017-06-24

8.  Usefulness of limb salvage surgery for bone and soft tissue sarcomas of the distal lower leg.

Authors:  Rui Niimi; Akihiko Matsumine; Katsuyuki Kusuzaki; Shigeyuki Kuratsu; Nobuhito Araki; Yasuaki Aoki; Takafumi Ueda; Ikuo Kudawara; Akira Myoui; Makoto Ieguchi; Nobuyuki Hashimoto; Hideki Yoshikawa; Atsumasa Uchida
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-02       Impact factor: 4.553

Review 9.  High infection rate outcomes in long-bone tumor surgery with endoprosthetic reconstruction in adults: a systematic review.

Authors:  Antonella Racano; Theresa Pazionis; Forough Farrokhyar; Benjamin Deheshi; Michelle Ghert
Journal:  Clin Orthop Relat Res       Date:  2013-02-12       Impact factor: 4.176

10.  Iterative curettage is associated with local control in giant cell tumors involving the distal tibia.

Authors:  Saleh A AlSulaimani; Robert E Turcotte
Journal:  Clin Orthop Relat Res       Date:  2013-04-09       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.